Words of Wisdom. Re: Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Eur Urol. 2016 Mar;69(3):538-9. doi: 10.1016/j.eururo.2015.12.025.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antineoplastic Agents / therapeutic use*
  • Carcinoma, Renal Cell / drug therapy*
  • Female
  • Humans
  • Kidney Neoplasms / drug therapy*
  • Male
  • Sirolimus / analogs & derivatives*

Substances

  • Antibodies, Monoclonal
  • Antineoplastic Agents
  • Sirolimus